KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation

American Journal of Pathology

Volumn 181, Issue 3, 2012, Pages 1007-1016

  Liu, Xiaomei ^a   Gomez Pinillos, Alejandro ^a   Loder, Charisse ^b   Carrillo De Santa Pau, Enrique ^c   Qiao, Ruifang ^d   Unger, Pamela D ^d   Kurek, Ralf ^e   Oddoux, Carole ^f   Melamed, Jonathan ^g   Gallagher, Robert E ^h   Mandeli, John ^d   Ferrari, Anna C ^a  

^a NEW YORK UNIVERSITY   (United States)

^b STRONG MEMORIAL HOSPITAL   (United States)

^c Centro Nacional de Investigations Oncológicas   (Spain)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Department of Radiation Oncology ^*  (Germany)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 6;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LOSS OF FUNCTION MUTATION; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; RNA SPLICING; SOMATIC MUTATION;

ALTERNATIVE SPLICING; ANDROGENS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EXONS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84865250699     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.06.008     Document Type: Article

References (27)

1. J.J. Bieker Kruppel-like factors: three fingers in many pies J Biol Chem 276 2001 34355 34358
2. A. DiFeo, G. Narla, O. Camacho-Vanegas, H. Nishio, S.L. Rose, R.E. Buller, S.L. Friedman, M.J. Walsh, J.A. Martignetti E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor Oncogene 25 2006 6026 6031
3. X. Huang, X. Li, B. Guo KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3 J Biol Chem 283 2008 29795 29801
4. S. Benzeno, G. Narla, J. Allina, G.Z. Cheng, H.L. Reeves, M.S. Banck, J.A. Odin, J.A. Diehl, D. Germain, S.L. Friedman Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1 Cancer Res 64 2004 3885 3891
5. E. Rodrguez, N. Aburjania, N.M. Priedigkeit, A. DiFeo, J.A. Martignetti Nucleo-cytoplasmic localization domains regulate Krppel-like factor 6 (KLF6) protein stability and tumor suppressor function PLoS One 5 2010 pii:e12639
6. G. Narla, K.E. Heath, H.L. Reeves, D. Li, L.E. Giono, A.C. Kimmelman, M.J. Glucksman, J. Narla, F.J. Eng, A.M. Chan, A.C. Ferrari, J.A. Martignetti, S.L. Friedman KLF6, a candidate tumor suppressor gene mutated in prostate cancer Science 294 2001 2563 2566
7. C. Chen, E.R. Hyytinen, X. Sun, H.J. Helin, P.A. Koivisto, H.F. Frierson Jr, R.L. Vessella, J.T. Dong Deletion, mutation, and loss of expression of KLF6 in human prostate cancer Am J Pathol 162 2003 1349 1354
8. K.R. Muhlbauer, H.J. Grone, T. Ernst, E. Grone, R. Tschada, M. Hergenhahn, M. Hollstein Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes Br J Cancer 89 2003 687 690
9. L. Agell, S. Hernandez, S. de Muga, J.A. Lorente, N. Juanpere, R. Esgueva, S. Serrano, A. Gelabert, J. Lloreta KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations Mod Pathol 21 2008 1470 1478
10. G. Narla, A. DiFeo, Y. Fernandez, S. Dhanasekaran, F. Huang, J. Sangodkar, E. Hod, D. Leake, S.L. Friedman, S.J. Hall, A.M. Chinnaiyan, W.L. Gerald, M.A. Rubin, J.A. Martignetti KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis J Clin Invest 118 2008 2711 2721
11. G. Narla, A. Difeo, H.L. Reeves, D.J. Schaid, J. Hirshfeld, E. Hod, A. Katz, W.B. Isaacs, S. Hebbring, A. Komiya, S.K. McDonnell, K.E. Wiley, S.J. Jacobsen, S.D. Isaacs, P.C. Walsh, S.L. Zheng, B.L. Chang, D.M. Friedrichsen, J.L. Stanford, E.A. Ostrander, A.M. Chinnaiyan, M.A. Rubin, J. Xu, S.N. Thibodeau, S.L. Friedman, J.A. Martignetti A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk Cancer Res 65 2005 1213 1222
12. N. Hanoun, C. Bureau, T. Diab, O. Gayet, N. Dusetti, J. Selves, J.P. Vinel, L. Buscail, P. Cordelier, J. Torrisani The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions J Hepatol 53 2010 880 888
13. E. Zaharieva, J.K. Chipman, M. Soller Alternative splicing interference by xenobiotics Toxicology 296 2012 1 12
14. A.C. Ferrari, N.N. Stone, R. Kurek, E. Mulligan, R. McGregor, R. Stock, P. Unger, U. Tunn, A. Kaisary, M. Droller, S. Hall, H. Renneberg, K.J. Livak, R.E. Gallagher, J. Mandeli Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment J Clin Oncol 24 2006 3081 3088
15. W.C. Wong, D. Kim, H. Carter, M. Diekhans, M.C. Ryan, R. Karchin CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer Bioinformatics 27 2011 2147 2148
16. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, G.L. Gallia, A. Olivi, R. McLendon, B.A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D.A. Busam, H. Tekleab, L.A. Diaz Jr, J. Hartigan, D.R. Smith, R.L. Strausberg, S.K. Marie, S.M. Shinjo, H. Yan, G.J. Riggins, D.D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, K.W. Kinzler An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
17. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. Kondrashov, S.R. Sunyaev A method and server for predicting damaging missense mutations Nat Methods 7 2010 248 249
18. X.M. Liu, A. Gomez-Pinillos, X.J. Liu, E.M. Johnson, A.C. Ferrari Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Pura-mediated decrease in androgen receptor levels Prostate 70 2010 179 189
19. L.G. Wang, L. Ossowski, A.C. Ferrari Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line Cancer Res 61 2001 7544 7551
20. J. Shi, Z. Hu, K. Pabon, K.W. Scotto Caffeine regulates alternative splicing in a subset of cancer-associated genes: a role for SC35 Mol Cell Biol 28 2008 883 895
21. A. Bar-Shira, N. Matarasso, S. Rosner, D. Bercovich, H. Matzkin, A. Orr-Urtreger Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6 Prostate 66 2006 1052 1060
22. Q. Pan, O. Shai, L.J. Lee, B.J. Frey, B.J. Blencowe Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing Nat Genet 40 2008 1413 1415
23. C. Ghigna, C. Valacca, G. Biamonti Alternative splicing and tumor progression Curr Genomics 9 2008 556 570
24. S.M. Dehm, D.J. Tindall Alternatively spliced androgen receptor variants Endocr Relat Cancer 18 2011 R183 R196
25. P.I. Poulikakos, Y. Persaud, M. Janakiraman, X. Kong, C. Ng, G. Moriceau, H. Shi, M. Atefi, B. Titz, M.T. Gabay, M. Salton, K.B. Dahlman, M. Tadi, J.A. Wargo, K.T. Flaherty, M.C. Kelley, T. Misteli, P.B. Chapman, J.A. Sosman, T.G. Graeber, A. Ribas, R.S. Lo, N. Rosen, D.B. Solit RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) Nature 480 2011 387 390
26. K. Yoshida, M. Sanada, Y. Shiraishi, D. Nowak, Y. Nagata, R. Yamamoto, Y. Sato, A. Sato-Otsubo, A. Kon, M. Nagasaki, G. Chalkidis, Y. Suzuki, M. Shiosaka, R. Kawahata, T. Yamaguchi, M. Otsu, N. Obara, M. Sakata-Yanagimoto, K. Ishiyama, H. Mori, F. Nolte, W.K. Hofmann, S. Miyawaki, S. Sugano, C. Haferlach, H.P. Koeffler, L.Y. Shih, T. Haferlach, S. Chiba, H. Nakauchi, S. Miyano, S. Ogawa Frequent pathway mutations of splicing machinery in myelodysplasia Nature 478 2011 64 69
27. C.V. Lefave, M. Squatrito, S. Vorlova, G.L. Rocco, C.W. Brennan, E.C. Holland, Y.X. Pan, L. Cartegni Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas EMBO J 30 2011 4084 4097